Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Hims & Hers Health Narrows FY2025 Sales Guidance from $2.300B-$2.400B to $2.335B-$2.355B vs $2.341B Est

Author: Benzinga Newsdesk | November 03, 2025 04:09pm
Hims & Hers Health (NYSE:HIMS) narrows FY2025 sales outlook from $2.300 billion-$2.400 billion to $2.335 billion-$2.355 billion vs $2.341 billion estimate.

Posted In: HIMS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist